ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 162 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $18,494,000 | -3.9% | 4,392,988 | -5.7% | 0.02% | -6.2% |
| Q4 2016 | $19,243,000 | -58.0% | 4,658,845 | -17.6% | 0.02% | -59.0% |
| Q3 2016 | $45,785,000 | +2.8% | 5,652,494 | -1.0% | 0.04% | +2.6% |
| Q2 2016 | $44,555,000 | -14.9% | 5,712,359 | -15.7% | 0.04% | -15.6% |
| Q1 2016 | $52,336,000 | -30.9% | 6,779,004 | -3.4% | 0.04% | -30.8% |
| Q4 2015 | $75,718,000 | -25.3% | 7,017,465 | -52.2% | 0.06% | +41.3% |
| Q3 2015 | $101,364,000 | +77.9% | 14,669,096 | +128.1% | 0.05% | -2.1% |
| Q2 2015 | $56,990,000 | +24.9% | 6,432,328 | +39.0% | 0.05% | +23.7% |
| Q1 2015 | $45,644,000 | +20.1% | 4,629,202 | +49.2% | 0.04% | +15.2% |
| Q4 2014 | $38,016,000 | +5.5% | 3,103,369 | -14.1% | 0.03% | 0.0% |
| Q3 2014 | $36,048,000 | +395.2% | 3,611,979 | +49.8% | 0.03% | +371.4% |
| Q3 2013 | $7,280,000 | -62.9% | 2,410,741 | +0.5% | 0.01% | -65.0% |
| Q2 2013 | $19,623,000 | – | 2,398,863 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $82,075,000 | 8.82% |
| RTW INVESTMENTS, LP | 1,622,633 | $19,877,000 | 7.35% |
| ProQuest Associates IV LLC | 1,122,957 | $13,757,000 | 6.97% |
| RA Capital Management | 2,500,000 | $30,625,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 517,450 | $6,339,000 | 3.03% |
| DAFNA Capital Management LLC | 197,500 | $2,419,000 | 1.91% |
| Rhenman & Partners Asset Management AB | 368,000 | $4,508,000 | 1.31% |
| SECTORAL ASSET MANAGEMENT INC | 2,373,810 | $29,079,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,920,300 | $35,774,000 | 1.28% |
| Bain Capital Public Equity Management, LLC | 2,928,750 | $35,877,000 | 0.90% |